ChemPartner PharmaTech Co Ltd (300149) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.012x

Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) has a cash flow conversion efficiency ratio of 0.012x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.21 Million ≈ $4.13 Million USD) by net assets (CN¥2.37 Billion ≈ $347.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ChemPartner PharmaTech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how ChemPartner PharmaTech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300149 total liabilities for a breakdown of total debt and financial obligations.

ChemPartner PharmaTech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ChemPartner PharmaTech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Thurgauer Kantonalbank SW:TKBP	-0.323x
Barclays PLC LSE:BARC	0.507x
Thermador Groupe SA PA:THEP	0.062x
Shenzhen Comix Group Co Ltd SHE:002301	0.030x
Top Resource Conservation Engineering Co Ltd SHE:300332	0.021x
Gresgying Digital Energy Technology Co Ltd SHG:600212	0.058x
Mobilicom Limited Warrants NASDAQ:MOBBW	-0.330x
Turkiye Sinai Kalkinma Bankasi AS IS:TSKB	0.071x

Annual Cash Flow Conversion Efficiency for ChemPartner PharmaTech Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market value of ChemPartner PharmaTech Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.24 Billion ≈ $181.17 Million	CN¥168.21 Million ≈ $24.61 Million	0.136x	+31.45%
2023-12-31	CN¥1.46 Billion ≈ $213.77 Million	CN¥150.99 Million ≈ $22.09 Million	0.103x	-6.04%
2022-12-31	CN¥2.39 Billion ≈ $349.14 Million	CN¥262.46 Million ≈ $38.41 Million	0.110x	-42.15%
2021-12-31	CN¥1.99 Billion ≈ $291.06 Million	CN¥378.22 Million ≈ $55.35 Million	0.190x	+35.89%
2020-12-31	CN¥2.45 Billion ≈ $358.86 Million	CN¥343.16 Million ≈ $50.22 Million	0.140x	+49.86%
2019-12-31	CN¥2.30 Billion ≈ $337.05 Million	CN¥215.07 Million ≈ $31.47 Million	0.093x	-15.36%
2018-12-31	CN¥2.20 Billion ≈ $322.59 Million	CN¥243.19 Million ≈ $35.59 Million	0.110x	+45.29%
2017-12-31	CN¥835.45 Million ≈ $122.25 Million	CN¥63.43 Million ≈ $9.28 Million	0.076x	-17.96%
2016-12-31	CN¥769.93 Million ≈ $112.67 Million	CN¥71.26 Million ≈ $10.43 Million	0.093x	-33.47%
2015-12-31	CN¥723.81 Million ≈ $105.92 Million	CN¥100.69 Million ≈ $14.73 Million	0.139x	+62.47%
2014-12-31	CN¥696.53 Million ≈ $101.92 Million	CN¥59.63 Million ≈ $8.73 Million	0.086x	+23.89%
2013-12-31	CN¥670.29 Million ≈ $98.08 Million	CN¥46.32 Million ≈ $6.78 Million	0.069x	-19.60%
2012-12-31	CN¥640.90 Million ≈ $93.78 Million	CN¥55.09 Million ≈ $8.06 Million	0.086x	+350.62%
2011-12-31	CN¥611.46 Million ≈ $89.48 Million	CN¥11.66 Million ≈ $1.71 Million	0.019x	-47.63%
2010-12-31	CN¥571.30 Million ≈ $83.60 Million	CN¥20.81 Million ≈ $3.05 Million	0.036x	-72.23%
2009-12-31	CN¥101.26 Million ≈ $14.82 Million	CN¥13.28 Million ≈ $1.94 Million	0.131x	-64.72%
2008-12-31	CN¥58.36 Million ≈ $8.54 Million	CN¥21.70 Million ≈ $3.18 Million	0.372x	-59.35%
2007-12-31	CN¥24.25 Million ≈ $3.55 Million	CN¥22.19 Million ≈ $3.25 Million	0.915x	--

About ChemPartner PharmaTech Co Ltd

SHE:300149 China Biotechnology

Market Cap

$727.95 Million

CN¥4.97 Billion CNY

Market Cap Rank

#10636 Global

#3121 in China

Share Price

CN¥9.99

Change (1 day)

-0.10%

52-Week Range

CN¥6.15 - CN¥14.24

All Time High

CN¥24.07